Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

Brain circuits

A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up. . . . → Read More: Gates, Lauder Backing Early Alzheimer’s Biomarker Tests

A.I. Drug Discovery Company Gains $32M in Early Funds

Brain hemispheres graphic

A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds

New $315 Million Life Sciences Venture Fund Unveiled

Investment graphic

A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled

Infographic – Amazon’s Largest Acquisitions

Acquisitions by amazon

Our friends at CB Insights put together a chart showing Amazon’s largest acquisitions in dollar value, this weekend’s infographic. . . . → Read More: Infographic – Amazon’s Largest Acquisitions

University Tissue, Cell Fabrication Lab Set to Open

3-D bioprinter

A laboratory for producing new types of biomaterials is scheduled to open next year on the University of Illinois campus in Urbana. . . . → Read More: University Tissue, Cell Fabrication Lab Set to Open

NIH Grant Funds New Spinal Cord Injury Treatment

Spine

A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury. . . . → Read More: NIH Grant Funds New Spinal Cord Injury Treatment

Univ. Spin-Off Developing Long-Lasting Diabetes Drug

Bathroom scale

A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight. . . . → Read More: Univ. Spin-Off Developing Long-Lasting Diabetes Drug

Cancer T-Cell Start-Up Gains $150 Million in IPO

NASDAQ share price display

A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO

$3.4M NIH Grant Funding New ALS Treatments

Brain cell networks

A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: $3.4M NIH Grant Funding New ALS Treatments

115M Euro Grant for Precision Medicine, Trials in Autism

Autism graphic

A new initiative in Europe is investigating the connection between a person’s molecular composition and autism, particularly when other disorders complicate that individual’s condition. . . . → Read More: 115M Euro Grant for Precision Medicine, Trials in Autism